Correlation Between Pfizer and RenovoRx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and RenovoRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and RenovoRx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and RenovoRx, you can compare the effects of market volatilities on Pfizer and RenovoRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of RenovoRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and RenovoRx.

Diversification Opportunities for Pfizer and RenovoRx

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pfizer and RenovoRx is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and RenovoRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RenovoRx and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with RenovoRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RenovoRx has no effect on the direction of Pfizer i.e., Pfizer and RenovoRx go up and down completely randomly.

Pair Corralation between Pfizer and RenovoRx

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the RenovoRx. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 4.99 times less risky than RenovoRx. The stock trades about -0.02 of its potential returns per unit of risk. The RenovoRx is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  64.00  in RenovoRx on August 26, 2024 and sell it today you would earn a total of  65.00  from holding RenovoRx or generate 101.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  RenovoRx

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
RenovoRx 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in RenovoRx are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, RenovoRx unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and RenovoRx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and RenovoRx

The main advantage of trading using opposite Pfizer and RenovoRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, RenovoRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RenovoRx will offset losses from the drop in RenovoRx's long position.
The idea behind Pfizer Inc and RenovoRx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes